Filing Details

Accession Number:
0000878088-11-000066
Form Type:
4
Zero Holdings:
No
Publication Time:
2011-09-07 14:39:25
Reporting Period:
2011-09-06
Filing Date:
2011-09-07
Accepted Time:
2011-09-07 14:39:25
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
878088 Par Pharmaceutical Companies Inc. PRX Pharmaceutical Preparations (2834) 223122182
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1055404 G Patrick Lepore C/O Par Pharmaceutical Companies, Inc.
300 Tice Blvd.
Woodcliff Lake NJ 07677
Chairman, President & Ceo Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2011-09-06 8,000 $25.92 23,000 No 4 P Indirect By Trust
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect By Trust
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 254,880 Direct
Common Stock 15,000 Indirect By Limited Partnership
Footnotes
  1. The shares are held by the Patrick LePore Revocable Trust of 2002, of which Mr. LePore is the Grantor, Trustee and beneficiary.
  2. Includes (i) 152,956 shares of Common Stock, and (ii) 101,924 shares of Restricted Stock and Restricted Stock Units, held by Mr. LePore.
  3. The shares are held by Park Street Investors, L.P. ("PSI"), a Delaware limited partnership. The General Partner of PSI is Park Street Investment Corporation ("PSIC"), a Delaware corporation, of which Mr. LePore and his spouse are officers and directors and together own a majority of the outstanding stock of PSIC.